Delivery Order SPE2DB22D3301-SPE2DB26FX3RE
- Not listed
- The Defense Logistics Agency awarded a $1,919.84 firm fixed price delivery order to AmerisourceBergen Drug Corp for the supply of Remifentanil 2 mg vials. This competitively awarded contract, which has no set-aside designation, was executed on July 9, 2025, with an ultimate completion date of July 10, 2025. AmerisourceBergen Drug Corp will perform the work at its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger...
- The Defense Logistics Agency awarded a delivery order valued at $11,983.47 to AmerisourceBergen Drug Corp for the supply of Remifentanil 2 mg vials, a potent opioid analgesic commonly used in clinical and surgical settings. This firm fixed-price delivery order, awarded on September 3, 2025, with an ultimate completion date of September 4, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The performance...
- The Defense Logistics Agency awarded a delivery order valued at $2,925.36 to AmerisourceBergen Drug Corp for the supply of Remifentanil 2 mg vials. This contract type represents a firm fixed price delivery order with an ultimate completion date of September 18, 2025, and was competitively awarded with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $2,266.63 on October 17, 2025, by the Defense Logistics Agency for the supply of Remifentanil 2 mg vials. This competitive award utilizes firm fixed pricing with an ultimate completion date of October 20, 2025. The contract is issued as a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 29, 2025, for the supply of Remifentanil 5 mg vials with a ceiling value of $27,502.30. This firm fixed-price delivery order, with an ultimate completion date of September 30, 2025, represents a competitively awarded, non-set-aside procurement with place of performance in Conshohocken, Pennsylvania. The award is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a delivery order valued at $3,426.20 to AmerisourceBergen Drug Corp for the supply of Remifentanil 2 mg vials, with an ultimate completion date of September 4, 2025. This non-set-aside contract employs firm fixed pricing and represents a competitively awarded delivery order under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The product will be delivered to AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $1,466.92 to AmerisourceBergen Drug Corp for the supply of Remifentanil 1 mg vials. This contract, awarded on October 17, 2025, with an ultimate completion date of October 20, 2025, is structured as a firm fixed-price delivery order with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Remifentanil is a potent opioid analgesic commonly used in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Remifentanil 1 mg vials, with a contract ceiling value of $4,947.88. This competitively awarded, firm fixed-price delivery order was executed on September 24, 2025, with an ultimate completion date of September 25, 2025. The work will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a $13,585.09 delivery order on September 19, 2025, for the supply of Remifentanil 2 mg vials. This is a competitively awarded, firm fixed-price contract with no set-aside designation and an ultimate completion date of September 22, 2025. The contract is funded by the Medical Supply Chain, a defense-focused federal agency supporting military and veteran healthcare systems. This...
- The Defense Logistics Agency awarded a $2,055.72 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Remifentanil 2 mg vials, with an ultimate completion date of August 11, 2025. This is a competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran...
- SPE2DB22D3301Indefinite Delivery Contract
- SPE2DB22D3301-SPE2DB26FX3REDelivery Order
The Defense Logistics Agency awarded a $11,238.43 delivery order to AmerisourceBergen Drug Corp for the supply of Remifentanil 2 mg vials under a firm fixed-price contract structure. The award, issued on October 22, 2025, with an ultimate completion date of October 23, 2025, represents a competitively awarded procurement with no set-aside designation. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, maintains a significant federal contract portfolio focused on supporting military and veteran healthcare systems. As a critical vendor within the DLA Medical Supply Chain, the company supplies a broad spectrum of pharmaceutical products and medical commodities to the Defense Health Agency, U.S. Coast Guard, and other government healthcare entities. The Remifentanil order fulfills federal medical procurement requirements for this opioid analgesic medication, commonly utilized in acute care and perioperative settings within military medical facilities. This award demonstrates the company's ongoing capability to meet federal procurement standards through open competition and its role as a key supplier within the Department of Defense's pharmaceutical distribution network.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.2k | 10/22/25 |